Broadly neutralizing antibodies (bNAbs) are thought to be the future for treating and preventing HIV infections. A bNAb recently characterized by Caltech researchers can neutralize HIV in different states—increasing the antibody's promise as a therapeutic.
Thanks to a three-year gift commitment from the Heritage Medical Research Institute (HMRI), Caltech and HMRI have established a new partnership that will provide nine Caltech faculty members with funding support to advance research that relates to medicine and patient care.
Using computational and experimental methods, researchers at Caltech have developed a technique for creating so-called protein–DNA nanowires—a hybrid biomaterial that could have important applications.
Nearly two dozen middle- and high-school students have been spending their summer studying biological systems in the field, classroom, and laboratory as part of the Community Science Academy @ Caltech.